Literature DB >> 15009816

Efficacy and pharmacokinetics of fluvoxamine maleate in patients with mild depression undergoing hemodialysis.

Toshiko Kamo1, Naoshi Horikawa, Yukio Tsuruta, Misako Miyasita, Hiroshi Hatakeyama, Yasuhiko Maebashi.   

Abstract

Seven Japanese patients on maintenance hemodialysis who were comorbid with mild depression were medicated with 50 mg/day fluvoxamine maleate for 28 days. Effectiveness was obtained in four out of seven patients (57%). The plasma fluvoxamine concentrations were examined in three patients. The plasma fuvoxamine concentration decreased by 22% by hemodialysis. There is a tendency for the dialyzed rate of fluvoxamine to become lower if the plasma albumin concentration is higher. The half-life of fluvoxamine was possibly shortened more in the patient with hypoalbuminaemia. The plasma fluvoxamine concentration reached a steady state 8 days after the start of medication and thereafter. The time required to reach steady state was lengthened when compared with the results in normal Japanese volunteers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009816     DOI: 10.1111/j.1440-1819.2003.01206.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  4 in total

1.  Patterns and predictors of depression treatment among adults with chronic kidney disease and depression in ambulatory care settings in the United States.

Authors:  Nina Vadiei; Sandipan Bhattacharjee
Journal:  Int Urol Nephrol       Date:  2018-12-04       Impact factor: 2.370

2.  Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.

Authors:  Magdalene M Assimon; M Alan Brookhart; Jennifer E Flythe
Journal:  J Am Soc Nephrol       Date:  2019-03-18       Impact factor: 10.121

3.  Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND).

Authors:  S Susan Hedayati; Divya M Daniel; Scott Cohen; Bryan Comstock; Daniel Cukor; Yaminette Diaz-Linhart; Laura M Dember; Amelia Dubovsky; Tom Greene; Nancy Grote; Patrick Heagerty; Wayne Katon; Paul L Kimmel; Nancy Kutner; Lori Linke; Davin Quinn; Tessa Rue; Madhukar H Trivedi; Mark Unruh; Steven Weisbord; Bessie A Young; Rajnish Mehrotra
Journal:  Contemp Clin Trials       Date:  2015-11-24       Impact factor: 2.226

Review 4.  Pharmacokinetics of antidepressants in patients undergoing hemodialysis: a narrative literature review.

Authors:  Juliana L Constantino; Vilma A Fonseca
Journal:  Braz J Psychiatry       Date:  2019-03-07       Impact factor: 2.697

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.